These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16974202)

  • 1. An exploratory open trial on safety and efficacy of the anticonvulsant retigabine in acute manic patients.
    Amann B; Sterr A; Vieta E; Stampfer R; Walden J; Grunze H
    J Clin Psychopharmacol; 2006 Oct; 26(5):534-6. PubMed ID: 16974202
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the new antiepileptic drug retigabine in a rodent model of mania.
    Dencker D; Dias R; Pedersen ML; Husum H
    Epilepsy Behav; 2008 Jan; 12(1):49-53. PubMed ID: 18086455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retigabine: fewer drug interactions.
    Prescrire Int; 2012 Mar; 21(125):61. PubMed ID: 22428181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezogabine (Potiga) for epilepsy.
    Med Lett Drugs Ther; 2012 Aug; 54(1397):65-7. PubMed ID: 22907178
    [No Abstract]   [Full Text] [Related]  

  • 5. Ezogabine (retigabine) and its role in the treatment of partial-onset seizures: a review.
    Splinter MY
    Clin Ther; 2012 Sep; 34(9):1845-56.e1. PubMed ID: 22917854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive use of ezogabine/retigabine with either traditional sodium channel blocking antiepileptic drugs (AEDs) or AEDs with other mechanisms of action: Evaluation of efficacy and tolerability.
    Brodie MJ; French JA; McDonald SA; Lee WJ; Adams B; Scott A; Nohria V; DeRossett S
    Epilepsy Res; 2014 Jul; 108(5):989-94. PubMed ID: 24726452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezogabine (Potiga) toxicity.
    Med Lett Drugs Ther; 2013 Nov; 55(1430):96. PubMed ID: 24276503
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.
    Brodie MJ; Lerche H; Gil-Nagel A; Elger C; Hall S; Shin P; Nohria V; Mansbach H;
    Neurology; 2010 Nov; 75(20):1817-24. PubMed ID: 20944074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies.
    Gil-Nagel A; Brodie MJ; Leroy R; Cyr T; Hall S; Castiglia M; Twomey C; VanLandingham K
    Epilepsy Res; 2012 Nov; 102(1-2):117-21. PubMed ID: 22771137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials.
    Porter RJ; Burdette DE; Gil-Nagel A; Hall ST; White R; Shaikh S; DeRossett SE
    Epilepsy Res; 2012 Aug; 101(1-2):103-12. PubMed ID: 22512894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retigabine. A novel anticonvulsant drug for the adjunctive treatment of partial seizures].
    Hecht B
    Med Monatsschr Pharm; 2012 May; 35(5):166-71. PubMed ID: 22624350
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany.
    Nass RD; Kurth C; Kull A; Graf W; Kasper B; Hamer HM; Strzelczyk A; Elger CE; Steinhoff BJ; Surges R; Rosenow F
    Epilepsy Behav; 2016 Mar; 56():54-8. PubMed ID: 26828693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use.
    Large CH; Sokal DM; Nehlig A; Gunthorpe MJ; Sankar R; Crean CS; Vanlandingham KE; White HS
    Epilepsia; 2012 Mar; 53(3):425-36. PubMed ID: 22221318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retigabine (ezogabine): in partial-onset seizures in adults with epilepsy.
    Deeks ED
    CNS Drugs; 2011 Oct; 25(10):887-900. PubMed ID: 21936589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures.
    Porter RJ; Partiot A; Sachdeo R; Nohria V; Alves WM;
    Neurology; 2007 Apr; 68(15):1197-204. PubMed ID: 17420403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant effect of retigabine during postnatal development in rats.
    Forcelli PA; Soper C; Lakhkar A; Gale K; Kondratyev A
    Epilepsy Res; 2012 Aug; 101(1-2):135-40. PubMed ID: 22483539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open prospective study of zonisamide in acute bipolar depression.
    Ghaemi SN; Zablotsky B; Filkowski MM; Dunn RT; Pardo TB; Isenstein E; Baldassano CF
    J Clin Psychopharmacol; 2006 Aug; 26(4):385-8. PubMed ID: 16855456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder.
    Dencker D; Husum H
    Behav Brain Res; 2010 Feb; 207(1):78-83. PubMed ID: 19815032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retigabine for partial onset seizures.
    Rheims S; Ryvlin P
    Expert Rev Neurother; 2012 May; 12(5):509-17. PubMed ID: 22550979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.